Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH

NCT00267670 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Nonalcoholic Steatohepatitis
Liver Diseases

Interventions

DRUG: Pentoxifylline
DRUG: Placebo

Sponsor

Northwestern University